The effect of resveratrol on the expression of AdipoR1 in kidneys of diabetic nephropathy

Molecular Biology Reports

Volumn 41, Issue 4, 2014, Pages 2151-2159

  Ji, Hongfei ^a   Wu, Lina ^a   Ma, Xiaokun ^a   Ma, Xiaojun ^a   Qin, Guijun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

AdipoR1; Diabetic nephropathy; Forkhead transcription factor O1; Resveratrol

Indexed keywords

ADIPONECTIN RECEPTOR 1; COLLAGEN TYPE 4; CREATININE; FIBRONECTIN; MALONALDEHYDE; NITROGEN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR FKHR; UREA; ADIPONECTIN RECEPTOR; ADIPONECTIN RECEPTOR 1, RAT; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, RAT; GLUCOSE; NERVE PROTEIN; STILBENE DERIVATIVE;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; KIDNEY CORTEX; KIDNEY MASS; MALE; MESANGIUM CELL; NONHUMAN; PROTEINURIA; RAT; UPREGULATION; UREA NITROGEN BLOOD LEVEL; ANIMAL; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; LIPID PEROXIDATION; METABOLISM; OXIDATIVE STRESS; PATHOLOGY;

RATTUS;

ANIMALS; BODY WEIGHT; COLLAGEN TYPE IV; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; FIBRONECTINS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GLUCOSE; KIDNEY; LIPID PEROXIDATION; MALE; MESANGIAL CELLS; NERVE TISSUE PROTEINS; OXIDATIVE STRESS; RATS; RECEPTORS, ADIPONECTIN; STILBENES;

EID: 84897520788     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3064-2     Document Type: Article

References (52)

1. Forbes JM, Coughlan MT, Cooper ME (2008) Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57:1446-1454
2. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C (2012) United States Renal Data System 2011 Annual data report: Atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis 59(A7):e1-e420
3. Blazquez-Medela AM, Lopez-Novoa JM, Martinez-Salgado C (2010) Mechanisms involved in the genesis of diabetic nephropathy. Curr Diabetes Rev 6:68-87
4. Singh DK, Winocour P, Farrington K (2011) Oxidative stress in early diabetic nephropathy: fueling the fire. Nat Rev Endocrinol 7:176-184
5. Fornoni A, Ijaz A, Tejada T, Lenz O (2008) Role of inflammation in diabetic nephropathy. Curr Diabetes Rev 4:10-17 (Pubitemid 351216880)
6. Wu L, Zhang Y, Ma X, Zhang N, Qin G (2012) The effect of resveratrol on FoxO1 expression in kidneys of diabetic nephropathy rats. Mol Biol Rep 39:9085-9093
7. Eid AA, Gorin Y, Fagg BM, Maalouf R, Barnes JL (2009) Mechanisms of podocyte injury in diabetes role of cytochrome P450 and NADPH oxidases. Diabetes 58:1201-1211
8. Briggs DB, Giron RM, Malinowski PR, Nuñez M, Tsao TS (2011) Role of redox environment on the oligomerization of higher molecular weight adiponectin. BMC Biochem 12:24
9. Wu X, Mahadev K, Fuchsel L, Ouedraogo R, Xu SQ et al (2007) Adiponectin suppresses IkappaB kinase activation induced by tumor necrosis factor-alpha or high glucose in endothelial cells: role of cAMP and AMP kinase signaling. Am J Physiol Endocrinol Metab 293:E1836-E1844 (Pubitemid 350258452)
10. Kim YL, Kim TK, Cheong ES, Shin DG, Choi GS (2012) Relation of absolute or relative adiposity to insulin resistance, retinol binding protein-4, leptin, and adiponectin in type 2 diabetes. Diabetes Metab J 36:415-421
11. Chan KH, Lam KS, Cheng OY, Kwan JS, Ho PW (2012) Adiponectin is protective against oxidative stress induced cytotoxicity in amyloid-beta neurotoxicity. PLoS One 7:e52354
12. Lee S, Park Y, Dellsperger KC, Zhang C (2011) Exercise training improves endothelial function via adiponectin-dependent and independent pathways in type 2 diabetic mice. Am J Physiol Heart Circ Physiol 301:H306-H314
13. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T et al (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769 (Pubitemid 36735700)
14. de Oliveira C, de Mattos AB, Silva CB, Mota JF, Zemdegs JC (2012) Nutritional and hormonal modulation of adiponectin and its receptors adipoR1 and adipoR2. Vitam Horm 90:57-94
15. Crimmins NA, Martin LJ (2007) Polymorphisms in adiponectin receptor genes ADIPOR1 and ADIPOR2 and insulin resistance. Obes Rev 8:419-423 (Pubitemid 47283939)
16. Dai MH, Xia T, Zhang GD, Chen XD, Gan L et al (2006) Cloning, expression and chromosome localization of porcine adiponectin and adiponectin receptors genes. Domest Anim Endocrinol 30:117-125 (Pubitemid 43077101)
17. Debard C, Laville M, Berbe V, Loizon E, Guillet C (2004) Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of type 2 diabetic patients. Diabetologia 47:917-925 (Pubitemid 38757006)
18. Cui XB, Wang C, Li L, Fan D, Zhou Y (2012) Insulin decreases myocardial adiponectin receptor 1 expression via PI3 K/Akt and FoxO1 pathway. Cardiovasc Res 93:69-78
19. Guo Z, Zhao Z (2007) Effect of N-acetylcysteine on plasma adiponectin and renal adiponectin receptors in streptozotocin-induced diabetic rats. Eur J Pharmacol 558:208-213 (Pubitemid 46328886)
20. Tamura Y, Murayama T, Minami M, Matsubara T, Yokode M (2012) Ezetimibe ameliorates early diabetic nephropathy in db/db mice. J Atheroscler Thromb 19:608-618
21. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C et al (2006) Resveratrol improves Mitochondrial function and Protects against metabolie disease by activating SIRT1 and PGC-1 alpha. Cell 127:1109-1122 (Pubitemid 44894520)
22. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C et al (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337-342 (Pubitemid 44764104)
23. Chen W, Rezaizadehnajafi L, Wink M (2013) Influence of resveratrol on oxidative stress resistance and life span in Caenorhabditis elegans. J Pharm Pharmacol 65:682-688
24. Tomé-Carneiro J, Larrosa M, Yáñez-Gascón MJ, Dávalos A, Gil-Zamorano J (2013) One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacol Res 72C:69-82
25. Mohar DS, Malik S (2012) The Sirtuin system: the Holy Grail of resveratrol? J Clin Exp Cardiolog 3:216
26. Ajmo JM, Liang X, Rogers CQ, Pennock B, You M (2008) Resveratrol alleviates alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 295:833-842
27. Huang H, Tindall DJ (2007) CDK2 and FOXO1: A fork in the road for cell fate decisions. Cell Cycle 6:902-906 (Pubitemid 46658742)
28. Furukawa-Hibi Y, Kobayashi Y, Chen C, Motoyama N (2005) FOXO transcription factors in cell-cycle regulation and the response to oxidative stress. Antioxid Redox Signal 7:752-760 (Pubitemid 40563215)
29. Puthanveetil P, Wan A, Rodrigues B (2013) FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell survival. Cardiovasc Res 97:393-403
30. Ponugoti B, Dong G, Graves DT (2013) Role of forkhead transcription factors in diabetes-induced oxidative stress. Exp Diabetes Res 2012:939751
31. Tsuchida A, Yamauchi T, Ito Y, Hada Y, Maki T et al (2004) Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin Sensitivity. J Biol Chem 279:30817-30822 (Pubitemid 38938015)
32. Sun X, He J, Mao C, Han R, Wang Z, Liu Y et al (2008) Negative regulation of adiponectin receptor 1 promoter by insulin via a repressive nuclear inhibitory protein element. FEBS Lett 582:3401-3407
33. Cui XB, Wang C, Li L, Fan D, Zhou Y (2012) Insulin decreases myocardial adiponectin receptor 1 expression via PI3 K/Akt and FoxO1 pathway. Cardiovasc Res 3:69-78
34. Felder TK, Hahne P, Soyal SM, Miller K, Höffinger H (2010) Hepatic adiponectin receptors (ADIPOR) 1 and 2 mRNA and their relation to insulin resistance in obese humans. Int J Obes (Lond) 34:846-851
35. Roy SK, Chen Q, Fu J, Shankar S, Srivastava RK (2011) Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors. PLoS One 6:e25166
36. Huang H, Iida KT, Sone H, Ajisaka R (2007) The regulation of adiponectin receptors expression by acute exercise in mice. Exp Clin Endocrinol Diabetes 115:417-422 (Pubitemid 47234640)
37. Chen Q, Ganapathy S, Singh KP, Shankar S, Srivastava RK (2010) Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells. PLoS One 5:e15288
38. Srivastava RK, Unterman TG, Shankar S (2010) FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol. Mol Cell Biochem 337:201-212
39. Qiang L, Banks AS, Accili D (2010) Uncoupling of acetylation from phosphorylation regulates FoxO1 function independent of its subcellular localization. J Biol Chem 285:27396-27401
40. Xia L, Wang H, Goldberg HJ, Munk S, Fantus IG et al (2006) Mesangial cell NADPH oxidase upregulation in high glucose is PKC dependent and required for Collagen IV expression. Am J Physiol Renal Physiol 290:F345-F356 (Pubitemid 43724989)
41. Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B et al (2005) NOX4 NADPH Oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 280:39616-39626 (Pubitemid 41713921)
42. Soler MJ, Riera M, Batlle D (2012) New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy. Exp Diabetes Res 2012:616313
43. Molitch ME, DeFronzo RA, Franz MJ, Keane WF, Mogensen CE (2004) Nephropathy in diabetes. Diabetes Care 27:S79-S83
44. Mazzucco G, Bertani T, Fortunato M, Bernardi M, Leutner M (2002) Different patterns of renal damage in type 2 diabetes mellitus: A multicentric study on 393 biopsies. Am J Kidney Dis 39:713-720 (Pubitemid 34263344)
45. Choi R, Kim BH, Naowaboot J, Lee MY, Hyun MR (2011) Effects of ferulic acid on diabetic nephropathy in a rat model of type 2 diabetes. Exp Mol Med 43:676-683
46. Nakamaki S, Satoh H, Kudoh A, Hayashi Y, Hirai H et al (2011) Adiponectin reduces proteinuria in streptozotocin-induced diabetic Wistar rats. Exp Biol Med 236:614-620
47. Klahrs (1999) Mechanisms of progression of chronic renal damage. J Nephrol 12:53-62
48. Barthel A, Schmoll D, Unterman TG (2005) FoxO proteins in insulin action and metabolism. Trends Endocrinol Metab 16:183-189 (Pubitemid 40603098)
49. Van Der Heide LP, Hoekman MF, Smidt MP (2004) The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation. Biochem J 380:297-309 (Pubitemid 38788101)
50. Jacobs FM, van der Heide LP, Wijchers PJ, Burbach JP, Hoekman MF (2003) FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics. J Biol Chem 278:35959-35967 (Pubitemid 37139914)
51. Rena G, Woods YL, Prescott AR, Peggie M, Unterman TG (2002) Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion. EMBO J 21:2263-2271 (Pubitemid 34516785)
52. Brunet A, Park J, Tran H, Hu LS, Hemmings BA (2001) Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Bioln 21:952-965 (Pubitemid 32104742)